Philips launches game-changing interventional platform for cardiology
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
IntraSight Plus enables confident decision-making and better patient care,” Philips said, emphasizing efficiency, simplicity, and precision
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
Since launching, the hospital has performed over 40 intestinal transplants, including 21 in 2025 alone
The milestone moves the company closer to its previously announced $120 million US expansion, with groundbreaking slated for late 2026
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
It promises fewer injections for vision loss patients
Call it a major breakthrough for diagnostic imaging
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
Subscribe To Our Newsletter & Stay Updated